Series A Metrics Benchmarks for European Startups 2026: What Investors Actually Demand (vs. What YC Claims)
Y Combinator publishes benchmarks, and founders memorize them. But what investors actually demand in Series A meetings in 2026 has drifted from YC's public playbook. The gap matters more in Europe
The Series A Reality: Whatâs Changed Since YCâs Public Benchmarks (2024-2026)
Quick answer: Series A investors want to see: $10K+ MRR (B2B SaaS), 50%+ month-over-month growth, $1M+ ARR trajectory (annualized run rate), and 12+ month runway. Metrics vary by vertical â B2C wants higher growth rates; B2B wants higher ACV and retention. Donât optimize just for Series A metrics. Optimize for real business health. Series A investors can smell artificial cohort selection and one-time revenue spikes.
Y Combinator publishes benchmarks, and founders memorize them. But what investors actually demand in Series A meetings in 2026 has drifted from YCâs public playbook. The gap matters more in Europe than in the US.
Iâve deployed âŹ150M+ across early-stage companies across Poland, Sweden, and Western Europe over the past decade. Iâve been the investor saying âyesâ and the investor saying âwe need to see more growth.â Iâve watched founders overfocus on the metrics YC talks about (30% month-over-month growth, âŹ10k MRR) and miss the metrics that actually move investor conviction in a tough market.
The core shift from 2024-2026: The Series A market has hardened on two dimensions. First, growth efficiency has become table stakes. A company hitting âŹ30k MRR with a customer acquisition cost that eats 18 months of revenue is not getting a Series A at a good price anymoreâif at all. Second, founder judgment under ambiguity matters more than headline metrics. Investors are spending more diligence time asking âHave these founders made hard tradeoffs?â and less time asking âDoes the MRR number feel right?â
In this article, Iâll walk through what metrics matter, what they mean, where European expectations differ from US norms, andâcriticallyâwho raises on lower metrics and why. This is the founderâs version of what Iâm looking for when I say âyes.â
Revenue Metrics: The Real Minimums, Medians, and Outliers
Letâs start with what everyone obsesses over first. How much revenue do you need?
For related context, see presenting metrics in pitch materials, and cap table implications of Series A.
The YC answer: âŹ5-10k MRR baseline; âŹ30k+ MRR to be âsafe.â
The reality: It depends. But let me be specific.
Minimum MRR to Get a Meeting
You donât need âŹ5k MRR to get a Series A meeting. Founders with âŹ1-2k MRR get investor meetings if the other signals are right. Iâve seen it. But you do need one of the following:
- Extremely clear retention and expansion signal (net revenue retention >110% even at small scale).
- Unmistakable category creation (youâre not fighting an incumbent market; youâre making something that didnât exist).
- Founder pedigree so strong that investors treat your early traction as âearly stage learningâ rather than âslow growth.â
The founder who sold a company, raised a Series B at a previous startup, or came from a relevant technical background can raise at âŹ1k MRR. The first-time founder with âŹ1k MRR gets polite passes.
The Median Series A Benchmark
In Western Europe (France, Germany, UK, Nordics) in 2026, the median Series A in B2B SaaS is happening between âŹ15-40k MRR. In Berlin and Stockholm, founders are raising at the lower end of that range. In London, you see higher starting MRR because the investor bar is rougher.
In CEE (Poland, Czechia, Hungary), the median is âŹ8-20k MRR. Investors are more founder-quality gated. Theyâll move faster on lower MRR if they trust the person running the show. Iâve seen strong Polish founders raise Series A at âŹ5k MRR with the right narrative. Iâve also seen weak ones stall at âŹ25k.
The gap is real, and it matters. A Polish founder hitting âŹ15k MRR with clean unit economics can raise at a 2-3x better price multiple than a Western European founder at âŹ10k MRR because the baseline investor assumption in CEE is âweâre betting on judgment, not traction yet.â
The Outlier Play
Who raises Series A on under âŹ3k MRR?
- Marketplace networks with extreme early unit economics (think âŹ0.30 CAC, 10% take rate, but tiny GMV because youâre proving the unit model). Investors care less about absolute revenue and more about âCan you scale this unit without changing it?â
- AI/LLM powered tools that launched in the last 18 months and are proving product-market fit through viral adoption curves rather than paying customer density. Midjourney, Claude apps, agent platforms. The category is young enough that proof points are different.
- Deep tech founders from world-class labs (CERN, Max Planck, Deepmind) with zero revenue but a technical thesis investors canât build in-house. The metric is different. Itâs âCan we hire this personâs team?â
- Founders with a previous billion-dollar exit who are proving product-market fit in a new category. The investor assumption is âIf theyâre paying attention to this, weâre missing something.â
This is not your path unless youâre in those buckets. Donât use outliers as your benchmark.
Growth Rates: MoM Growth Expectations by Market and Product Type
This is where European founders get it wrong most often.
YC says 30% month-over-month growth. Every founder in Europe thinks thatâs the target. Itâs not.
The Wrong Obsession: Absolute Growth Rate
Hereâs what I see in pitch decks. A founder shows me a slide with a hockey stick that says â50% MoM growth.â I ask âWhatâs your CAC?â Silence. I ask âWhatâs your payback period?â Different silence. The growth rate is disconnected from whether that growth is profitable to acquire.
The better metric is efficient growth rate: MoM revenue growth divided by customer acquisition spend as a percentage of revenue. A company growing 15% MoM with a 1.2x CAC:LTV ratio is more valuable to an investor than a company growing 40% MoM with a 3x CAC:LTV ratio that will never reach profitability.
But let me give you the straight numbers because thatâs what youâre asking.
B2B SaaS (Vertically Focused, <âŹ100k ACV)
Western Europe / UK / Nordics:
- To raise at strong terms: 8-15% MoM growth
- Typical Series A range: 5-12% MoM
- Lower end acceptable: 3-5% MoM (if expansion revenue is >30% of new revenue)
CEE:
- Typical range: 4-10% MoM
- Lower end: 2-4% MoM (with strong founder signal)
This sounds conservative. It is. In 2026, growth efficiency matters more than growth speed. A company with 8% MoM and 12-month payback is raising a Series A at a better price than a company with 15% MoM and 24-month payback.
B2C / Community / Viral Motion Products
Western Europe:
- Typical range: 15-40% MoM user growth
- Series A happens at: 20-35% MoM (with clear monetization path)
- Lower end: 8-15% MoM (requires strong retention curve >60% D30)
CEE:
- Typical range: 10-30% MoM
- Investors are more skeptical of pure user growth without revenue. Theyâll ask âWhatâs the unit of revenue?â earlier.
The gap here is smaller because viral products have less local arbitrage. A consumer app winning in Stockholm plays by the same growth metrics as one in Berlin.
Marketplace / Network Products
Growth metrics for marketplaces are lies by default. Two-sided growth is not comparable to single-sided SaaS growth.
What investors actually care about:
- Seller GMV growth (if seller-side is your constraint)
- Active buyer percentage (what % of registered users transacted last month)
- Repeat purchase rate (how many buyers came back more than once)
A marketplace growing 20% MoM in GMV but with a 35% active buyer ratio and 2x repeat is less healthy than a marketplace growing 12% MoM with a 55% active buyer ratio and 4x repeat.
Donât send a Series A pitch deck with just â125% GMV growthâ as your growth headline. Send the buyer repeat curve and the merchant concentration. Thatâs what moves conviction.
When Lower Growth Is Actually Acceptable
You can raise Series A with single digit MoM growth if:
- Expansion revenue is >30% of net new revenue. (Your existing customers are growing faster than youâre acquiring new ones.)
- CAC payback is under 14 months. (The money you spent to get the customer comes back within a year.)
- Your category is winner-take-most and you have distribution you canât replicate. (E.g., youâre embedded in a workflow and competitors canât dislodge you without 2-3 years of engineering.)
- Net revenue retention is >120%. (Expansion revenue alone justifies the Series A investment.)
If you have one of these, you can get away with 4-6% MoM growth. If you have two, investors will move faster.
Unit Economics: What CAC:LTV Ratio Investors Actually Care About
Hereâs where founder math breaks down most often.
The Myth: âWe need a 3:1 CAC:LTV ratioâ
This is wrong. Not the principleâthe specific number. The right ratio depends on your payback period, your churn, and your growth rate.
A company with a 2:1 CAC:LTV ratio and a 10-month payback is more fundable than a company with a 3:1 CAC:LTV ratio and a 22-month payback. The 2:1 company recycles cash faster. The 3:1 company needs more working capital to scale.
What Investors Are Actually Checking
When I look at unit economics, Iâm checking three things:
- Gross margin. Is it >70% for B2B SaaS? <50% is a red flag unless you have a specific reason (e.g., youâre a marketplace taking 20% take rate with direct unit contribution at 5x CAC).
- Payback period. Can you recycle the money you spent to acquire the customer within 12-18 months? If not, every dollar of Series A capital has to sit in working capital instead of fueling growth.
- Churn. Are you bleeding customers faster than you can acquire them profitably? A 5% monthly churn with 8% MoM new revenue growth is not sustainable at scale.
The Numbers: Whatâs Actually Healthy
For B2B SaaS raising Series A:
- Gross margin: 75%+ (healthy), 70-75% (acceptable with strong growth), <70% (needs explanation)
- Payback period: 10-14 months (strong), 14-18 months (acceptable), >18 months (re-think unit economics)
- CAC:LTV: 2.0 - 3.5 (range depends on payback; higher payback = lower ratio acceptable)
- Monthly churn: 3-5% (healthy), 5-7% (acceptable if NRR is >110%), >7% (needs deep dive)
Hereâs how to think about it. A company with âŹ1000 ACV, a 3-month payback period, and a 4% monthly churn can support a 3.5:1 CAC:LTV ratio because the payback is so fast that cash recycles every quarter.
A company with âŹ5000 ACV, a 20-month payback period, and a 4% monthly churn needs a 2.0-2.2:1 CAC:LTV ratio because cash sits longer and every point of churn hurts more.
Investor Heresy: CAC:LTV Is Backward-Looking
The best founders Iâve backed stop thinking about CAC:LTV in the Series A and start thinking about future unit economics. They ask: âIf I hire great sales, whatâs the CAC tomorrow? If I improve onboarding, whatâs the churn tomorrow?â
This is why unit economics improve dramatically post-Series A. Founders whoâve proven the core product work (hence the funding) now have resources to optimize acquisition and retention.
Customer Concentration: Whatâs Dangerous vs. Whatâs Healthy
If your top three customers are 60% of revenue, you donât have a repeatable business model. You have a consulting shop that looks like SaaS.
But whatâs the right threshold?
The Concentration Risk Spectrum
Top 1 customer >40% of revenue: Red flag. Investors will model a scenario where you lose them. The equity value goes negative.
Top 3 customers >60% of revenue: Major concern. Investors will price a concentration discountâusually 20-30% off valuation. You need an exceptional story for why this is temporary.
Top 10 customers >80% of revenue: Acceptable only if youâre still in early sales mode (you only have 15 customers total and three of them are pilots). Once youâre past 50 customers, this is a bad sign.
Top 10 customers <60% of revenue: Healthy. Youâve achieved product-market fit in multiple segments.
How Customer Concentration Changes During Series A
Hereâs what I tell founders. Investors expect your concentration to improve slightly or hold steady during the Series A funding period. If youâre at 60% top-3 concentration when you raise, investors assume youâll get to 50% by the end of Year 1. If you stay at 60%, youâll have a harder time raising Series B.
The way to solve this is not to lose the big customers. Itâs to acquire 3-4 new large customers alongside them. Growing revenue from âŹ100k to âŹ200k with the same top 3 customers improves your concentration from 60% to 45% automatically.
Where This Differs Between US and Europe
US investors sometimes accept higher concentration from founders with prior exits or from category creators (e.g., âYouâre the only company doing Xâ) â repeat founder metrics expectations are genuinely different. European investors care more about customer diversity as a signal of repeatability. If your concentration is high, European investors assume you got lucky with a single sales motion and canât repeat it.
Burn Rate and Runway: How Much It Matters vs. Revenue Growth
Thereâs a myth that âburn doesnât matter if youâre growing fast enough.â
This is only half true.
The Real Calculation
The metric investors care about is gross burn multiple: How much cash are you burning per dollar of gross profit?
A company burning âŹ100k/month and generating âŹ50k in gross profit has a 2x gross burn multiple. A company burning âŹ100k/month and generating âŹ200k in gross profit has a 0.5x gross burn multiple.
The second company can raise at a better price because every dollar it burns is matched by 2x dollars of cash generation. The first company is bleeding. Every month itâs negative on cash because burn exceeds gross profit.
Whatâs Acceptable for Series A
Healthy profile:
- Gross burn multiple <1.5x (youâre burning less than gross profit)
- Runway >18 months (you can survive a slow Series B fundraise)
- Payback >12 months (you have time to iterate on unit economics)
Risky profile:
- Gross burn multiple >2.5x (youâre bleeding capital)
- Runway <12 months (youâre fundraising under desperation)
- Payback >24 months (investors worry youâll blow through Series A capital)
The founder narrative that changes everything: âWe could be cash-flow positive at âŹ500k ARR with no new hires, or we can hire aggressively and reach âŹ2M ARR in 18 months. Weâre choosing the latter because the market is moving fast.â Investors love this because it shows youâre making a choice, not running out of money.
Where Burn Rate Differs by Geography
In the US, investors sometimes fund heavy burn in hot categories (AI, fintech) because the velocity of capital and exits is fast. In Europe, investor patience is lower. A European investor will ask âWhy are you burning âŹ150k/month?â with more skepticism than a US investor.
This is not moralizing. Itâs capital arithmetic. US fund sizes and exit valuations allow for higher burn. European funds need higher efficiency to generate returns.
Product Metrics: Retention, Expansion Revenue, and NPS by Category
Revenue and growth tell you whatâs happening. Product metrics tell you why itâs happening and whether itâs sustainable.
Net Revenue Retention: The Metric That Predicts Series B
Hereâs the uncomfortable truth. A company with 90% gross retention (losing 10% of customers) and 50% expansion revenue (existing customers spending 50% more) can be healthier than a company with 95% gross retention and 0% expansion.
Why? The first company is generating âŹ1.45 in revenue from every euro of baseline revenue (the âŹ1.00 baseline plus the âŹ0.45 from expansion, minus the âŹ0.10 churn loss). The second company is generating âŹ0.95âitâs shrinking.
The benchmarks:
B2B SaaS (Series A stage):
-
120% NRR (greatâexpansion is outpacing churn)
- 110-120% NRR (goodâyouâre growing your install base)
- 100-110% NRR (acceptableâflat on installed base, growing through new logos)
- <100% NRR (problemâyouâre shrinking on aggregate revenue)
B2C Community / Network (Series A stage):
- N/A for most B2C (NRR doesnât apply the same way; look at DAU retention and monetization curve instead)
Marketplace (Series A stage):
- Look at repeat rate for repeat-purchase categories (e-commerce, ride-share)
- Look at merchant GMV growth for repeat-merchant categories (B2B2C)
Retention Curves: What Investors Are Actually Analyzing
When I look at retention, Iâm not just looking at â90% gross retention.â Iâm looking at the retention curve shape.
The healthy curve: Steep drop in month 1 (power users stay, casual users churn), flattens by month 3-4 (core users emerge). By month 12, youâre retaining 60-75% of cohorts.
The warning curve: Slow but steady decline across all months. By month 6, youâve lost 50% of users. This suggests the product doesnât have a âcore use caseââdifferent users are trying it for different reasons, none of which stick.
The doomed curve: Early plateau that lasts 4-6 months, then falls off a cliff. This often means youâve exhausted your beachhead market, and the product doesnât extend to new use cases.
European investors analyze retention curves more obsessively than US investors because exit timelines in Europe are longer. You need to prove the product sticks for years, not quarters.
Net Promoter Score: The Underrated Metric
Most founders donât track NPS formally at Series A. They should.
An NPS >50 is exceptional (you have product-market fit and word-of-mouth). An NPS >30 is solid (customers are satisfied enough to reference you). An NPS <20 is a problemâyouâre selling features, not solving problems.
Investors donât usually ask for NPS in formal data rooms, but when they do customer reference calls, theyâre measuring it informally. If your customers grudgingly admit âit worksâ and spend three minutes explaining why, you have low NPS. If they say âWe canât imagine operating without this,â you have high NPS.
Team Composition: What Investors Check
Hereâs what nobody says directly. At Series A, the team matters as much as the metrics.
The Checklist Investors Actually Use
CEO (the founder)
- Has raised capital before? (Yes = signal of execution skill)
- Has founded before? (Yes = signal of pattern recognition)
- Has operated in your target market? (Yes = signal of domain knowledge)
- Can articulate why now? (Yes = signal of market timing)
CTO (if technical product)
- Has built and shipped production systems? (Yes = less likely to take shortcuts)
- Has managed engineering teams? (Yes = can scale without choking)
- Do their GitHub contributions or past projects exist publicly? (Yes = easy verification)
VP Sales / Commercial (or operator if doing sales yourself)
- Has sold in this category before? (Yes = understands customer psychology)
- Has hit quota consistently? (Yes = not a theoretical salesperson)
- Can show customer references (not just names)? (Yes = credibility signal)
What Investors Donât Care About:
- âWe hired a VP Sales from Google/Salesforce.â (Title inflation is real.)
- âOur team has 50 years of combined experience.â (Irrelevant if spread across 8 people with no shared context.)
- âWeâre backed by [famous advisor].â (Advisors give credibility; they donât build products.)
The Hiring Pace Question
Investors ask: âHow fast can you hire?â
The right answer is: âWe can hire 3-4 strong engineers in the next 6 months, 1 data person, and 1 customer success operator. Weâre not hiring sales because Iâm hitting quota alone.â
The wrong answer is: âWeâre hiring 15 people in the next year because we need to scale.â
The first answer shows constraint prioritization. The second shows dilution anxietyâyouâre trying to hire away your problems instead of solving them.
Where European Teams Differ
Polish and CEE founding teams have higher technical depth on average (more founders with PhD or deep research backgrounds). This is an advantage for deep tech and developer tools. Itâs a disadvantage for pure go-to-market categories where you need sales velocity over technical rigor.
Western European teams (Germany, France) have more balanced technical + business founders. UK teams skew sales/business. Scandinavian teams are more design-focused.
Investors know this. Theyâre not penalizing you for being a technical founder from Warsaw. Theyâre calibrating risk differently. You have product risk thatâs lower but go-to-market risk that may be higher.
European vs. US Series A Expectations: Where It Differs
Let me spell this out clearly because many European founders miss this.
Revenue Expectations
| Metric | US Series A | Western EU Series A | CEE Series A |
|---|---|---|---|
| Minimum MRR | âŹ5-10k | âŹ8-15k | âŹ5-10k |
| Median MRR | âŹ30-50k | âŹ15-40k | âŹ8-20k |
| Typical growth rate | 8-15% MoM | 5-12% MoM | 4-10% MoM |
Why the difference? US Series A investors have higher tempo. Theyâre managing 40-60 companies per partner. European investors manage 20-30 companies per partner. They spend more time on diligence, so theyâre okay with lower headline metrics if the founder thesis is compelling. If you can articulate why youâre going to own a market (not just âweâre growing fasterâ), European investors move.
Valuation Expectations
A US Series A at âŹ30k MRR might price the company at 8-10x ARR (i.e., âŹ2.88M on âŹ360k ARR). A Western European Series A at the same metrics might price at 5-6x ARR (âŹ2.16M). A CEE Series A might price at 3-4x ARR (âŹ1.44M).
This is real dilution impact. A European founder raising âŹ1M at 4x ARR gives up 33% of the company. A US founder at the same check size at 8x ARR gives up 15%.
The tradeoff: CEE valuations are lower, but capital is cheaper (lower burn assumptions) and follow-on Series B financing is easier because the bar was more conservative.
Board Composition and Control
US Series A investors often take a board seat and assume significant operational involvement. European investors more often take an observer seat, especially in early or CEE-backed rounds. This is a founder advantage if you want autonomy. Itâs a disadvantage if you need deep financial/operational help.
Pro Rata Rights and Follow-On Expectations
US investors almost always take pro rata rights (the right to lead future rounds proportionally). They actively expect to deploy 2-3x their Series A amount in Series B and C.
European investors take pro rata rights but are less aggressive on follow-on. Some European angels will explicitly say âIâm taking 0.5x pro rataâ to signal theyâre not committing to Series B.
This changes negotiation dynamics. If an investor has strong pro rata expectations, theyâre more selective upfront (they want to be able to write a âŹ5M Series B check). If they have weak pro rata expectations, theyâre more open early (they donât need the company to scale 10x; a 3-5x return works).
Due Diligence Depth and Timeline
US Series A due diligence typically takes 4-8 weeks from first investor meeting to term sheet. European Series A can take 8-16 weeks. German investors are particularly slow (theyâre checking everything). UK investors are faster (theyâre on US tempo).
CEE investors are variable. A strong Polish VC can move in 4 weeks if they trust the founder. A more cautious fund might take 12 weeks.
The implication: Polish founders should expect diligence friction if raising from Western European investors. German investor scrutiny on cap table, legal structure, and IP is thorough and non-negotiable. Plan for it.
The Outliers: Who Raises on Lower Metrics (and Why)
I want to be explicit about the exceptions because founders use outliers as excuses too often.
Category: Founders with Prior Exits >âŹ100M
If you sold a company for âŹ100M+, you can raise a Series A at âŹ2k MRR if:
- The team is intact from the exit
- The new product is in a related market
- You can articulate the distribution advantage from the last company
Examples: The Slack founders raising Slackhq, the Figma core team spinning up new tools, etc.
This is not your path if: Youâre a first-time founder or you exited a âŹ10M company. The bar for âweâve been here beforeâ is high.
Category: AI/ML Model Builders (18-Month Window)
Between 2024-2025, the AI wave was strong enough that investors funded AI teams with zero revenue if:
- The founders were from Anthropic, OpenAI, DeepMind, or equivalent
- The product was a clear application of new capabilities (GPT4 / Claude integration) that didnât exist before
- The team had product-market fit signals in 8-12 weeks (DAU, usage hours, retention)
This is narrowing in 2026. The bar is getting higher. You need meaningful traction within 3 months, not just âwe have a great model.â
Category: Deep Tech with Institutional Distribution
If you have a deep tech product (chip design, climate tech, biotech) and a relationship with a large industrial customer or government program:
- You can raise on low revenue because the customer development is the validation
- You can show LOIs, pilot programs, or procurement pathway evidence
- The customer is willing to co-invest or partner
Examples: EV charging hardware raising on pilot deployments, industrial software raising on integrated partnership with Siemens, etc.
This is not your path if: Your customer âmightâ be interested. They need to be actively engaged in the development.
Category: Marketplace / Network with Extreme Unit Economics Proof
If youâre a marketplace and youâve proven:
- âŹ5000+ in annual GMV per seller (with <âŹ500 CAC)
-
50% repeat rate for buyers
- <30 day time to first transaction
You can raise on âŹ1-2k in GMV revenue because the unit model is so clean that investors see the scaling path.
Examples: B2B marketplaces raising on founder-operated pilots (youâre the only salesperson), lateral marketplaces raising on organic expansion.
This is not your path if: Youâve only been operating for 2 months. You need 6+ months of data.
Up Next
- Negotiate Series A in a Tough Market
- One-Pager That Gets Investor Meetings
- Cap Table Health Check
- The Second-Time Founderâs Advantage
FAQ
{
"@context": "https://schema.org",
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "What's the minimum MRR to raise a Series A in Europe?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Technically you can get investor meetings at âŹ1-2k MRR if you have founder pedigree (prior exit, repeat founder) or unmistakable product-market fit signals. The realistic minimum for non-outlier founders is âŹ5-10k MRR in CEE and âŹ8-15k MRR in Western Europe. Median Series A happens at âŹ8-20k MRR in CEE and âŹ15-40k MRR in Western Europe."
}
},
{
"@type": "Question",
"name": "How much month-over-month growth do I need for Series A?",
"acceptedAnswer": {
"@type": "Answer",
"text": "For B2B SaaS in Europe, 5-12% MoM growth is typical. For B2C viral products, 15-40% MoM user growth. The key is that growth efficiency (growth relative to CAC and payback period) matters more than the absolute growth rate. A company with 8% MoM growth and 12-month payback is more fundable than a company with 15% MoM growth and 24-month payback."
}
},
{
"@type": "Question",
"name": "What CAC:LTV ratio do investors require for Series A?",
"acceptedAnswer": {
"@type": "Answer",
"text": "There's no single number. Investors care about CAC:LTV in context of payback period and churn. A company with 2:1 CAC:LTV and 10-month payback is healthier than 3:1 CAC:LTV and 22-month payback. For Series A, 2.0-3.5x CAC:LTV is the normal range, but the acceptable ratio depends on payback period and gross retention."
}
},
{
"@type": "Question",
"name": "How much does customer concentration matter for Series A?",
"acceptedAnswer": {
"@type": "Answer",
"text": "If your top 3 customers are >60% of revenue, investors will discount valuation 20-30%. If top 1 customer is >40% of revenue, it's a major red flag. Healthy target: top 10 customers <60% of revenue and improving customer diversification by year-end."
}
},
{
"@type": "Question",
"name": "Why are European Series A expectations lower than US expectations?",
"acceptedAnswer": {
"@type": "Answer",
"text": "European investors manage fewer companies per partner (20-30 vs. 40-60 in the US) and spend more time on diligence. They value founder thesis and execution track record more heavily than pure headline metrics. US investors move faster and accept higher burn multiples. Valuations reflect this: European founders raise at 4-6x ARR vs. US founders at 8-10x ARR on similar metrics."
}
}
]
}
Frequently Asked Questions
Q: If I havenât hit Series A metrics yet, should I delay or raise Series A anyway?
Raise anyway if you have traction (5K-20K MRR), strong retention (80%+ monthly), and growth momentum (month-over-month growth trend visible). Series A investors care about trajectory, not hitting arbitrary benchmarks. If your growth is accelerating, your Series A is oversubscribed. If growth is flat or declining, wait 6 months and improve.
Q: How do I present metrics without cherry-picking data?
Show monthly trailing numbers, not just the best month. Show: MRR trend (Jan $5K, Feb $6K, Mar $8K, Apr $11K). This is honest and shows growth. Donât show: âOne customer pays $50K so our ARR is $600K.â Show actual recurring revenue. Investors have seen every cherry-pick trick. Honesty is more impressive.
Q: Do European founders need different benchmark targets than US founders?
Not really. Series A expectations are global for SaaS. Growth rates might be 30% MoM instead of 50%, but the ranges are similar. European bootstrapped companies sometimes grow slower and hit Series A with lower burn rate. Thatâs fine. Investors adjust expectations for market. But absolute metrics (MRR, ARR, retention) are consistent.
Q: What if my best metric is not what investors normally care about?
Lead with it anyway. If youâre a B2B company with higher unit economics (lower MRR, higher customer lifetime value), lead with LTV and CAC ratio. If youâre marketplace with low GMV but high take rate, lead with take rate and number of repeat transactors. Investors adapt if you explain the metric.
Q: How do I calculate Series A valuation based on my metrics?
Series A valuations are typically 3-8x ARR for SaaS. If your ARR is $600K, Series A valuation is $1.8M-$4.8M. If your growth rate is 50% MoM, multiply by 1.5. These are rules of thumb, not formulas. Your actual valuation depends on market, competition, and investor demand. Use benchmarks as anchors, not targets.
Series A Metrics: The business performance indicators that Series A investors use to predict company trajectory. Core metrics are MRR, growth rate, retention, and runway. Series A metrics differ by vertical (B2B SaaS focuses on ACV and CAC; B2C focuses on DAU and retention). Metrics should reflect actual business health, not optimized subsets.